Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America.
PLoS Pathog. 2023 Sep 8;19(9):e1011195. doi: 10.1371/journal.ppat.1011195. eCollection 2023 Sep.
Toxin-antitoxin (TA) systems are ubiquitous two-gene loci that bacteria use to regulate cellular processes such as phage defense. Here, we demonstrate the mechanism by which a novel type III TA system, avcID, is activated and confers resistance to phage infection. The toxin of the system (AvcD) is a deoxycytidylate deaminase that converts deoxycytidines (dC) to dexoyuridines (dU), while the RNA antitoxin (AvcI) inhibits AvcD activity. We have shown that AvcD deaminated dC nucleotides upon phage infection, but the molecular mechanism that activated AvcD was unknown. Here we show that the activation of AvcD arises from phage-induced inhibition of host transcription, leading to degradation of the labile AvcI. AvcD activation and nucleotide depletion not only decreases phage replication but also increases the formation of defective phage virions. Surprisingly, infection of phages such as T7 that are not inhibited by AvcID also lead to AvcI RNA antitoxin degradation and AvcD activation, suggesting that depletion of AvcI is not sufficient to confer protection against some phage. Rather, our results support that phage with a longer replication cycle like T5 are sensitive to AvcID-mediated protection while those with a shorter replication cycle like T7 are resistant.
毒素-抗毒素 (TA) 系统是细菌用来调节细胞过程(如噬菌体防御)的普遍存在的双基因座。在这里,我们展示了一种新型 III 型 TA 系统 avcID 被激活并赋予噬菌体感染抗性的机制。该系统的毒素 (AvcD) 是一种脱氧胞苷脱氨酶,可将脱氧胞苷 (dC) 转化为脱氧尿苷 (dU),而 RNA 抗毒素 (AvcI) 抑制 AvcD 活性。我们已经表明,AvcD 在噬菌体感染时脱氨基 dC 核苷酸,但激活 AvcD 的分子机制尚不清楚。在这里,我们表明 AvcD 的激活源于噬菌体诱导的宿主转录抑制,导致不稳定的 AvcI 降解。AvcD 的激活和核苷酸耗竭不仅降低了噬菌体的复制,而且增加了缺陷噬菌体病毒粒子的形成。令人惊讶的是,感染不受 AvcID 抑制的噬菌体,如 T7,也会导致 AvcI RNA 抗毒素降解和 AvcD 激活,这表明 AvcI 的耗竭不足以赋予对某些噬菌体的保护。相反,我们的结果表明,复制周期较长的噬菌体,如 T5,对 AvcID 介导的保护敏感,而复制周期较短的噬菌体,如 T7,则具有抗性。